Cybin
Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms. Learn more
Launch date
Employees
Market cap
€132m
Enterprise valuation
€10m (Public information from Sep 2024)
Share price
$8.56 CYBN
Ontario California (HQ)
Authorizing premium user...